NVMI:NASDAQNova Ltd. Analysis
Data as of 2026-06-21 - not real-time
$575.31
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Nova Ltd. (NVMI) is trading at $575.31, comfortably above its 20‑day ($526.92) and 50‑day ($517.86) SMAs and the 200‑day SMA ($407.22), confirming a strong bullish bias. The MACD histogram is positive (+5.92) and the MACD line sits well above its signal line, while the RSI at 58 indicates momentum is still intact without being overbought. Volume is increasing and the price is holding well above the identified support at $474.35, with the next resistance near $616, suggesting room for short‑term upside.
Fundamentally, the company posted 10.3% YoY revenue growth to $235.3 M and beat consensus earnings, raising Q2 guidance 3.8% above expectations. However, the current PE of 71.9× versus an industry average of 38.1× and a DCF fair value of $87.61 imply the stock is heavily overvalued, with an upside/downside projection of only ~3.9%. The balance sheet shows ample cash ($1.10 B) but a high debt‑to‑equity of 57.7% and a beta of ~2.7, indicating elevated volatility and market risk. The consensus recommendation is a "strong buy" amid extreme greed sentiment, but the valuation gap and geopolitical exposure temper enthusiasm for longer horizons.
Fundamentally, the company posted 10.3% YoY revenue growth to $235.3 M and beat consensus earnings, raising Q2 guidance 3.8% above expectations. However, the current PE of 71.9× versus an industry average of 38.1× and a DCF fair value of $87.61 imply the stock is heavily overvalued, with an upside/downside projection of only ~3.9%. The balance sheet shows ample cash ($1.10 B) but a high debt‑to‑equity of 57.7% and a beta of ~2.7, indicating elevated volatility and market risk. The consensus recommendation is a "strong buy" amid extreme greed sentiment, but the valuation gap and geopolitical exposure temper enthusiasm for longer horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup with price above key SMAs
- Earnings beat and raised guidance
- Increasing volume supporting momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth and high operating margins
- Persistently high valuation multiples relative to peers
- Exposure to semiconductor cycle and geopolitical tensions
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- DCF fair value far below current price
- High beta and volatility indicating market sensitivity
- Potential headwinds from regulatory/export controls
Key Metrics & Analysis
Financial Health
Revenue Growth10.30%
Profit Margin29.21%
P/E Ratio71.9
ROE22.25%
ROA8.40%
Debt/Equity57.67
P/B Ratio13.9
Op. Cash Flow$217.1M
Free Cash Flow$122.4M
Industry P/E38.1
Technical Analysis
TrendBullish
RSI58.3
Support$474.35
Resistance$615.99
MA 20$526.92
MA 50$517.86
MA 200$407.22
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$87.61
Target Price$597.63
Upside/Downside3.88%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.69
Volatility82.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.